Cargando…

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

BACKGROUND: Weight change during chemotherapy is reported to be associated with a worse prognosis in breast cancer patients, both with weight gain and weight loss. However, most studies were conducted prior to the common use of anthracycline-base chemotherapy and on North American populations with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thivat, Emilie, Thérondel, Sophie, Lapirot, Olivier, Abrial, Catherine, Gimbergues, Pierre, Gadéa, Emilie, Planchat, Eloïse, Kwiatkowski, Fabrice, Mouret-Reynier, Marie A, Chollet, Philippe, Durando, Xavier
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006393/ https://www.ncbi.nlm.nih.gov/pubmed/21108799 http://dx.doi.org/10.1186/1471-2407-10-648

Ejemplares similares

Quality of life for older patients with cancer: a review of the evidence supporting melatonin use
por: Ginzac, Angeline, et al.
Publicado: (2020)

Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials
por: Abrial, Catherine, et al.
Publicado: (2009)

Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer
por: Passildas‐Jahanmohan, Judith, et al.
Publicado: (2021)

A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
por: Ginzac, Angeline, et al.
Publicado: (2020)

Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives
por: Durando, Xavier, et al.
Publicado: (2005)

Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
por: Ginzac, Angeline, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients
por: Lusho, Sejdi, et al.
Publicado: (2021)

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
por: Thivat, Emilie, et al.
Publicado: (2023)

Effect of an intensive 3-week preoperative home rehabilitation programme in patients with chronic obstructive pulmonary disease eligible for lung cancer surgery: a multicentre randomised controlled trial
por: Laurent, Hélène, et al.
Publicado: (2017)

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial
por: Biau, Julian, et al.
Publicado: (2020)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
por: Antoun, Sami, et al.
Publicado: (2019)

Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
por: Thivat, Emilie, et al.
Publicado: (2022)

Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial
por: Bingula, Rea, et al.
Publicado: (2018)

Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?
por: Chollet, P, et al.
Publicado: (2003)

INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer
por: Veyssière, Hugo, et al.
Publicado: (2021)

TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer
por: Gay-Bellile, Mathilde, et al.
Publicado: (2017)

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer
por: Chollet, P, et al.
Publicado: (2002)

Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe)
por: Vasson, Marie-Paule, et al.
Publicado: (2020)

For better or worse: Relationship change in Thailand during COVID-19
por: Wiwattanapantuwong, Juthatip, et al.
Publicado: (2022)

Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
por: Bortolini Silveira, Amanda, et al.
Publicado: (2021)

The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2
por: Saavedra Santa Gadea, Omar, et al.
Publicado: (2017)

ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2016)

From bad to worse: airline boarding changes in response to COVID-19
por: Islam, T., et al.
Publicado: (2021)

Discrete Emotion Profiles in Old Age: Stability and Change for Better or Worse
por: Hamm, Jeremy, et al.
Publicado: (2021)

RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire
por: Veyssiere, Hugo, et al.
Publicado: (2023)

Assessment of (99m)Tc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT)
por: Thivat, Emilie, et al.
Publicado: (2022)

Long-term improvement of breast cancer survivors’ quality of life by a 2-week group physical and educational intervention: 5-year update of the ‘PACThe’ trial
por: Kwiatkowski, Fabrice, et al.
Publicado: (2017)

Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program
por: Cabel, Luc, et al.
Publicado: (2021)

EVERYTHING HAS CHANGED FOR THE WORSE: EXPERIENCES OF ELDERS DISPLACED BY ARMED CONFLICT IN ETHIOPIA
por: Gebeyaw, Getachew, et al.
Publicado: (2022)

Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy
por: Guiu, S., et al.
Publicado: (2013)

Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on Their Condition
por: Gutierrez, Jesús, et al.
Publicado: (2016)

Sex-Specific Linkages Between Taxonomic and Functional Profiles of Tick Gut Microbiomes
por: Obregón, Dasiel, et al.
Publicado: (2019)

Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma
por: Timerman, Dmitriy, et al.
Publicado: (2016)

Curriculum changes for pre-registration nursing education in times of COVID-19: For the better or worse?
por: Seah, Betsy, et al.
Publicado: (2021)

Correction to: EVERYTHING HAS CHANGED FOR THE WORSE: EXPERIENCES OF ELDERS DISPLACED BY ARMED CONFLICT IN ETHIOPIA
Publicado: (2023)

Changes in liver mitochondrial plasticity induced by brain tumor
por: Pouliquen, Daniel, et al.
Publicado: (2006)

Weight Changes in Women Receiving Chemotherapy for Non-Metastatic Breast Cancer in Saudi Arabia
por: Al-Hajeili, Marwan, et al.
Publicado: (2021)

Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer
por: Tan, Winston, et al.
Publicado: (2022)

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib
por: Dufour, Robin, et al.
Publicado: (2015)

Individual factors associated with L- and H-type Bovine Spongiform Encephalopathy in France
por: Sala, Carole, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_22k5lqg3jk388t6iig5h016dcb